the Mayo Cardiac Sarcoid Registry


About this study

Aims, purpose, or objectives:

  1. Develop a retrospective registry of patients with cardiac sarcoidosis
  2. Develop a prospective registry of patients with cardiac sarcoidosis
  3. Understand the natural history of cardiac sarcoidosis through evaluation of outcomes of patients in the registry
  4. Determine risk factors for sarcoid involvement of the heart
  5. Evaluate outcomes of patients both treated and untreated with cardiac sarcoidosis
  6. Understand the complications of untreated and treated cardiac sarcoidosis


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adults evaluated in any Cardiology clinic with the diagnosis of probable or definite sarcoidosis. 

Exclusion Criteria: 

Patients declining to participate in the prospective registry.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Andrew Rosenbaum, M.D.

Open for enrollment

Contact information:

Andrew Rosenbaum M.D.

Jacksonville, Fla.

Mayo Clinic principal investigator

Leslie Cooper, M.D.

Contact us for the latest status

Contact information:

Andrew Rosenbaum M.D.

More information


Publications are currently not available